Ono Pharmaceutical GAAP EPS of ¥146.07, revenue of ¥397.04B; reaffirms FY outlook
Source: SeekingAlpha
2026-02-02 01:11:53 ET
More on Ono Pharmaceutical Co., Ltd.
- Ono Pharmaceutical Co., Ltd. (OPHLY) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow
- Ono Pharmaceutical Co., Ltd. (OPHLY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Seeking Alpha’s Quant Rating on Ono Pharmaceutical Co., Ltd.
- Historical earnings data for Ono Pharmaceutical Co., Ltd.
- Dividend scorecard for Ono Pharmaceutical Co., Ltd.
Read the full article on Seeking Alpha
For further details see:
Ono Pharmaceutical GAAP EPS of ¥146.07, revenue of ¥397.04B; reaffirms FY outlook
Ono Pharmaceutical Co Ltd ADR
NASDAQ: OPHLY
OPHLY Trading
-0.94% G/L:
$4.9845 Last:
88,072 Volume:
$4.98 Open:
